No Data
No Data
Earnings Troubles May Signal Larger Issues for Henan Jindan Lactic Acid TechnologyLtd (SZSE:300829) Shareholders
Henan Jindan Lactic Acid Technology (300829.SZ): cumulative repurchase of 1.12% of shares
Gelonghui November 1st | Henan Jindan Lactic Acid Technology (300829.SZ) announced that as of October 31, 2024, the company repurchased 2,079,180 shares of the company through the share repurchase special securities account in a centralized competitive bidding trading method, accounting for 1.12% of the total share capital. The highest fill price was 15.50 yuan/share, the lowest fill price was 13.23 yuan/share, and the total fill amount was RMB 30,041,503.90 (excluding trading taxes and fees).
Jindan Technology: Report for the third quarter of 2024
henan jindan lactic acid technology (300829.SZ) released its performance for the first three quarters, with a net income of 0.102 billion yuan, a year-on-year increase of 7.1%.
Henan Jindan Lactic Acid Technology (300829.SZ) released the third quarter report of 2024, with revenue for the first three quarters reaching...
Henan Jindan Lactic Acid Technology (300829.SZ): Currently the main products are lactic acid, sodium lactate, and calcium lactate.
Gelonghui October 10th | Henan Jindan Lactic Acid Technology (300829.SZ) stated on the investor interaction platform that the company's main products are lactic acid, sodium lactate, and calcium lactate. Lactic acid, as an organic acid naturally present in the human body, has good biocompatibility, can be fully absorbed by the human body. The lactic acid series products have functions such as preservation, freshness, and improvement of food flavor, and are widely used as additives in the fields of food, fodder, medicine, etc.; in addition, lactic acid can also synergistically enhance the efficacy with other additives to replace sodium dehydroacetate. Sodium dehydroacetate, as a food additive, has been widely used in baking and roasted foods in the past.
Henan Jindan Lactic Acid TechnologyLtd (SZSE:300829) Could Be Struggling To Allocate Capital
No Data